S 
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC 2070.SR · SAR
Health Care · Tadawul · 🇸🇦 Saudi Arabia
24.55
+1.40%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in SAR, from our data supplier.
Revenue
SAR 1.71bn
FY2016FY2025
Net income
SAR 184.4m
FY2016FY2025
Free cash flow
SAR 172.8m
FY2016FY2025
Shareholders' equity
SAR 1.60bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 1.71bn | SAR 1.68bn | SAR 1.65bn | SAR 1.43bn | SAR 1.46bn | SAR 1.56bn | SAR 1.55bn | SAR 1.27bn | SAR 1.39bn | SAR 1.84bn |
| Gross profit | SAR 832.6m | SAR 837.0m | SAR 708.1m | SAR 566.3m | SAR 619.9m | SAR 691.8m | SAR 550.8m | SAR 620.4m | SAR 704.5m | SAR 909.4m |
| Research and development | SAR 60.5m | SAR 76.0m | SAR 36.7m | SAR 42.6m | SAR 8.1m | SAR 20.4m | SAR 32.1m | SAR 34.9m | SAR 33.4m | SAR 30.0m |
| Operating income | SAR 266.2m | SAR 138.0m | SAR 89.4m | −SAR 101.1m | SAR 43.9m | SAR 235.6m | −SAR 96.9m | SAR 620.4m | SAR 193.5m | SAR 271.8m |
| Net income | SAR 184.4m | SAR 24.5m | −SAR 13.7m | −SAR 170.2m | SAR 26.5m | SAR 124.8m | −SAR 481.1m | SAR 102.8m | SAR 197.4m | SAR 376.7m |
| Diluted earnings per share | 1.99 | 0.21 | -0.11 | -1.42 | 0.25 | 1.04 | -4.01 | 0.86 | 1.64 | 3.14 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | SAR 4.37bn | SAR 4.32bn | SAR 4.02bn | SAR 3.83bn | SAR 4.43bn | SAR 4.68bn | SAR 4.62bn | SAR 4.77bn | SAR 4.77bn | SAR 4.84bn |
| Cash and short-term investments | — | SAR 277.6m | SAR 276.0m | SAR 380.8m | SAR 896.0m | SAR 1.07bn | SAR 379.0m | SAR 270.0m | SAR 211.6m | SAR 439.9m |
| Total liabilities | SAR 2.61bn | SAR 2.79bn | SAR 2.36bn | SAR 2.14bn | SAR 2.44bn | SAR 2.61bn | SAR 2.50bn | SAR 4.77bn | SAR 4.77bn | SAR 4.84bn |
| Debt | SAR 462.2m | SAR 1.51bn | SAR 1.12bn | SAR 1.08bn | SAR 1.29bn | SAR 1.35bn | SAR 1.21bn | SAR 1.02bn | SAR 804.4m | SAR 784.8m |
| Shareholders' equity | SAR 1.60bn | SAR 1.38bn | SAR 1.51bn | SAR 1.54bn | SAR 1.84bn | SAR 1.92bn | SAR 1.93bn | SAR 2.64bn | SAR 2.73bn | SAR 2.97bn |
| Shares outstanding | 93m | 119m | 120m | 120m | 108m | 120m | 120m | 120m | 120m | 120m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | SAR 272.4m | −SAR 331.0m | SAR 47.7m | −SAR 124.2m | SAR 86.7m | SAR 9.7m | SAR 350.0m | −SAR 80.5m | SAR 155.3m | SAR 9.4m |
| Capital spending | −SAR 99.6m | −SAR 67.0m | −SAR 117.4m | −SAR 84.6m | −SAR 83.9m | −SAR 183.4m | −SAR 341.6m | −SAR 281.0m | −SAR 234.7m | −SAR 310.5m |
| Free cash flow | SAR 172.8m | −SAR 398.0m | −SAR 69.6m | −SAR 208.8m | SAR 2.8m | −SAR 173.6m | SAR 8.4m | −SAR 361.5m | −SAR 79.3m | −SAR 301.1m |
| Dividends paid | — | −SAR 2.8m | −SAR 461,000 | −SAR 70.7m | −SAR 118.1m | −SAR 59.0m | −SAR 118.1m | −SAR 176.0m | −SAR 116.5m | −SAR 87.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | SAR 492.9m | SAR 423.8m | SAR 405.8m | SAR 415.3m | SAR 400.8m | SAR 484.8m | SAR 386.2m | SAR 447.0m |
| Gross profit | SAR 240.1m | SAR 236.1m | SAR 206.7m | SAR 202.9m | SAR 194.1m | SAR 228.9m | SAR 190.7m | SAR 216.6m |
| Operating income | SAR 91.3m | SAR 94.8m | SAR 57.8m | SAR 51.5m | SAR 61.4m | SAR 84.5m | SAR 11.2m | SAR 32.2m |
| Net income | SAR 68.4m | SAR 65.1m | SAR 29.7m | SAR 42.1m | SAR 32.6m | SAR 70.8m | −SAR 28.7m | −SAR 8.0m |
| Diluted earnings per share | 0.57 | 0.55 | 0.32 | 0.45 | 0.35 | 0.76 | -0.24 | -0.07 |
| Cash from operations | −SAR 71.0m | SAR 111.0m | SAR 82.0m | SAR 79.0m | SAR 91.0m | SAR 18.0m | −SAR 38.0m | −SAR 107.0m |
| Capital spending | −SAR 21.0m | −SAR 10.0m | −SAR 45.0m | −SAR 18.0m | −SAR 16.0m | −SAR 17.0m | −SAR 6.0m | −SAR 6.0m |
| Free cash flow | −SAR 92.0m | SAR 101.0m | SAR 37.0m | SAR 61.0m | SAR 75.0m | SAR 1.0m | −SAR 44.0m | −SAR 113.0m |
| Total assets | SAR 4.36bn | SAR 4.27bn | SAR 4.37bn | SAR 4.44bn | SAR 4.51bn | SAR 4.49bn | SAR 4.32bn | SAR 4.47bn |
| Cash and short-term investments | — | — | — | SAR 351.3m | SAR 436.2m | SAR 341.9m | SAR 277.6m | SAR 340.2m |
| Debt | SAR 486.1m | SAR 344.1m | SAR 462.2m | SAR 1.43bn | SAR 1.58bn | SAR 1.56bn | SAR 1.50bn | SAR 1.56bn |
| Shareholders' equity | SAR 1.69bn | SAR 1.66bn | SAR 1.60bn | SAR 1.55bn | SAR 1.50bn | SAR 1.46bn | SAR 1.38bn | SAR 1.47bn |
Financial ratios
Data as of 20 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 48.8% | 49.8% | 42.8% | 39.7% | 42.5% | 44.4% |
| Operating margin | 17.8% | 8.2% | 5.8% | -6.9% | 3.7% | 12.3% |
| Net margin | 10.8% | 1.5% | -0.8% | -11.9% | 1.8% | 8.0% |
| Return on equity | 11.5% | 1.8% | -0.9% | -11.1% | 1.4% | 6.5% |
| Return on assets | 4.2% | 0.6% | -0.3% | -4.4% | 0.6% | 2.7% |
| Free cash flow yield | 10.1% | -9.5% | 1.4% | -3.5% | 2.8% | 0.3% |
| Revenue growth | 1.5% | 1.7% | 15.9% | -2.3% | -6.4% | 0.4% |
| Earnings growth | 651.6% | -278.9% | -91.9% | -743.5% | -78.8% | -125.9% |
| Current ratio | 1.28x | 1.17x | 1.41x | 1.39x | 1.50x | 1.70x |
| Debt to equity | 0.29x | 1.09x | 0.74x | 0.69x | 0.69x | 0.70x |
| Equity ratio | 36.6% | 31.9% | 37.4% | 40.2% | 41.4% | 40.9% |
| Interest coverage | 3.10x | 1.44x | 1.61x | -2.78x | 1.74x | 5.75x |
| R&D as a share of sales | 3.5% | 4.5% | 2.2% | 3.0% | 0.6% | 1.3% |
| Buybacks as a share of market value | 22.2% | 0.4% | 0.2% | -11.5% | 10.3% | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 6.2% | 1.8% | 0.0% |
| Operating income | — | 2.5% | 0.2% |
| Net income | — | 8.1% | -6.4% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 49.3% | 45.5% | 44.9% | 45.6% |
| Operating margin | 11.9% | 6.1% | 7.1% | 11.1% |
| Net margin | 6.2% | 0.4% | 1.9% | 4.2% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 13.1 | 155.3 | -330.2 | -15.3 | 160.1 | 37.7 | -6.8 | 34.3 | 18.3 | 13.0 |
| Price to sales | 1.4 | 2.3 | 2.7 | 1.8 | 2.9 | 3.0 | 2.1 | 2.8 | 2.6 | 2.7 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 9 Jun 2022.
| FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.60 | 1.00 | 0.50 | 1.00 | 1.50 | 1.00 | 1.00 | 1.50 |
- 1.529-for-1 split · 20 Apr 2014
- 5-for-1 split · 15 Apr 2006
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.